FDA Issues Guidance on Using EHR Data in Clinical Studies
The Food and Drug Administration this week issued guidance intended to clarify the agency’s expectations when electronic health records are used as a source of data in clinical investigations. The guidance applies to clinical investigations of human drugs and biological products, medical devices and combination products, including investigations conducted in clinical practice settings.
Related News Articles
Headline
The Cybersecurity and Infrastructure Security Agency, Environmental Protection Agency, National Security Agency, FBI and international agencies Aug. 13…
Headline
The Centers for Medicare & Medicaid Services July 30 announced the creation of a “digital health ecosystem” that includes partnerships with health care…
Headline
The AHA Oct. 4 commented on the Department of Health and Human Services' Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing…
Headline
The AHA and the Electronic Health Record Association Sept. 23 filed an amicus brief in the U.S. Court of Appeals for the Fourth Circuit, challenging a Maryland…
Headline
In a letter to the Centers for Medicare & Medicaid Services and Office of the National Coordinator for Health Information Technology, AHA Jan. 2 expressed…
Chairperson's File
Nearly 15 years ago, a study published in the New England Journal of Medicine estimated that only 1.5% of acute care general medical and surgical hospitals had…